Dr. Philippe Verplancke member of CDISC E3C
XClinical’s CEO Dr. Philippe Verplancke becomes CDISC E3C member
(firmenpresse) - XClinical GmbH, Munich, Germany – Apr 23, 2009 – XClinical, a European vendor of innovative software products for eClinical trials, today announced the election of its CEO Dr. Philippe Verplancke as a member of the European CDISC Coordinating Committee (E3C). After a series of interviews with representatives of the industry, the current E3C members decided to appoint Dr. Philippe Verplancke. “I’m very happy to help promote the adoption of CDISC standards throughout Europe”, Dr. Verplancke pointed out.
In 2007, XClinical’s EDC system MARVIN was the first system which received the CDISC certification for the full compliance with the CDISC Operational Data Model (ODM). Hence, it is not surprising that Dr. Philippe Verplancke already has concrete plans. “I want to specifically contribute my experiences in CDISC ODM and define.xml standards to show how these standards can be used to improve clinical data management processes.”
The E3C, consisting of up to ten members, was founded to support global CDISC initiatives within Europe and provide regional feedback to the central CDISC organization. The Committee is responsible for the organization of the European CDISC activities. E3C members organize events like the annual Interchange Conferences, the CDISC roadshows as well as trainings and seminars. They also support the CDISC User Groups in European countries. Furthermore they are in close contact with EMEA and national competent authorities.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About XClinical
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was used to collect and process data of more than 50,000 patients in 70+ studies.
Datum: 24.04.2009 - 09:56 Uhr
Sprache: Deutsch
News-ID 1787
Anzahl Zeichen: 0
contact information:
Contact person: Katharina Lang
Town:
Munich
Phone: +49 (0)89 4522775220
Kategorie:
Healthcare & Medical
Typ of Press Release: Company
type of sending: send
Date of sending: 24.4.2009
Diese Pressemitteilung wurde bisher 904 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dr. Philippe Verplancke member of CDISC E3C"
steht unter der journalistisch-redaktionellen Verantwortung von
XClinical GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
